Health
MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines – News-Medical.Net
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells…
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted…
Continue Reading
-
General23 hours agoSmall team of rowers from Perth represents Australia on world skiffie stage
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 15 June 2025
-
Noosa News23 hours agoElderly driver killed in crash on Mount Coot-tha
-
General19 hours agoBenjamin Netanyahu and Ali Khamenei — the men behind the Middle East’s latest conflict